Thorax · 2003 · 192 citations · 26 references
Veterinary MedicineInfectious DiseasesMicrobiologyDiagnostic MicrobiologyMedical MicrobiologyPulmonologyFungal InfectionsPulmonary InfectionsRespiratory DiseaseRespiratory InfectionsRespiratory Infectious DiseasesRespiratory Tract InfectionsBronchiectasis-associated InfectionBronchoalveolar Lavage AnalysisBronchoalveolar Lavage ExaminationBronchoscopyGrocott Methenamine Silver StainingPneumocystis InfectionPrevalence EstimationPulmonary Fungal Infections
BACKGROUND: The opportunistic fungus Pneumocystis jiroveci is a common cause of respiratory infection in immunocompromised patients. By contrast, pneumocystis pneumonia (PCP) occurs only rarely in immunocompetent individuals. Asymptomatic colonisation with P jiroveci has recently been described in patients who are either minimally immunosuppressed or who have underlying lung disorders such as bronchiectasis. We sought to determine the prevalence of asymptomatic colonisation by P jiroveci in a cohort of adult patients undergoing diagnostic bronchoscopy. METHODS: A prospective observational cohort study was performed in patients who required bronchoscopy and bronchoalveolar lavage (BAL) as part of their routine clinical assessment. All the samples underwent standard microbiological analysis and a Grocott methenamine silver stain was performed where clinically indicated to detect the presence of P jiroveci. Polymerase chain reaction for detection of P jiroveci specific DNA was also performed. RESULTS: Ninety three consecutive BAL fluid samples were analysed, 17 (18%) of which contained P jiroveci DNA. Of the potential predictors examined, only glucocorticoid use was significantly associated with detectable P jiroveci DNA. Eighteen patients were receiving oral glucocorticoids (equivalent to >20 mg/day prednisolone) at the time of bronchoscopy, of whom eight (44%) had detectable P jiroveci DNA. In contrast, P jiroveci was detected in only nine of 75 patients (12%) who were not receiving glucocorticoids (difference between proportions 32%, 95% CI 8 to 57; p=0.004, two tailed Fisher's exact test). CONCLUSIONS: P jiroveci colonisation, as determined by detection of P jiroveci DNA in BAL fluid, is common in HIV negative patients with primary respiratory disorders undergoing bronchoscopy and BAL. The higher prevalence in patients receiving corticosteroids suggests that oral glucocorticoid therapy is an independent risk factor for colonisation. In contrast, underlying lung cancer or COPD did not appear to be risk factors.
26
Detection of Pneumocystis carinii with DNA amplification
Ann E. Wakefield, Fiona J. Pixley, Suneale Banerji et al. · The Lancet · 1990 · 401 citations
[Detection of Pneumocystis carinii with DNA amplification].
Kazuhiro Kitada, Yoichi Nakamura · PubMed · 1992 · 393 citations
PNEUMOCYSTIS CARINII PNEUMONIA
F. Gabriel Botella, J V Balaguer Martínez, M. Labiós Gómez et al. · The Medical Journal of Australia · 1964 · 312 citations